0.20Open0.20Pre Close0 Volume856 Open Interest7.50Strike Price0.00Turnover379.03%IV85.54%PremiumApr 17, 2025Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type0.2024Delta0.1266Gamma20.75Leverage Ratio-0.0427Theta0.0001Rho4.20Eff Leverage0.0017Vega
Cumberland Pharmaceuticals Stock Discussion
Breakthrough DMD Heart Disease Treatment Achieves 5.4% Function Boost While Controls Decline
$Cumberland Pharmaceuticals (CPIX.US)$
Cumberland Pharmaceuticals Inc -Vibativ Receives Marketing Approval in China
VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA
Tuesday, 18th February at 7:30 am
Vibativ® is a life-saving antibiotic for pneumonia and serious skin infections
Approval in China paves the way for launch in world's second-largest market
NASHVILLE, Tenn. and SHANGHAI, Feb. 18, 2025 /PRNewswire/ -- Specialty pharmaceutical companies Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) and SciClone Pharmaceuticals (Holdings) Limited ("SciClone Pharmaceuticals" o...
No comment yet